DACH1 A Key Protein For Tumor Suppression In ER+ Breast Cancer, Kimmel Cancer Institute Study
7/15/2009 7:37:07 AM
ScienceDaily (July 15, 2009) — Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer. The study was reported in the July 15 issue of Cancer Research.
comments powered by